okrętownictwo Kolejny formuła polo like kinase Kolonialny Północny Łaskotanie
Mitotic Roles of Polo Like Kinase
Continuous polo-like kinase 1 activity regulates diffusion to maintain centrosome self-organization during mitosis | PNAS
Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor? | HTML
Role of polo-like kinase 1 (PLK1) overexpression in cancer. In addition... | Download Scientific Diagram
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Polo-like Kinase Inhibitor V, Poloxin - CAS 321688-88-4 - Calbiochem The Polo-like Kinase Inhibitor
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Figure 3 from Polo-like kinases: structural variations lead to multiple functions | Semantic Scholar
Targeting Polo-like Kinase in Cancer Therapy | Clinical Cancer Research
QIAGEN - GeneGlobe Pathways - Mitotic Roles of Polo Like Kinases
Regulation of mitotic progression by Polo-like kinase 1 (PLK1). PLK1... | Download Scientific Diagram
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence? | Cancer Research
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Structure and function of the human Polo-like kinases: (A) Polo-like... | Download Scientific Diagram
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia
Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy - Eur. J. Med. Chem. - X-MOL
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis | HTML
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
The polo-like kinase family. Schematic representation of the five... | Download Scientific Diagram
Polo-Like Kinase-1 | SpringerLink
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas | Oncology
PLK1 - Wikipedia
Polo-like Kinase 1 Inhibitors and Their Potential Role in Anticancer Therapy, with a Focus on NSCLC | Clinical Cancer Research
Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment - ScienceDirect